DCVC Bio Investors
DCVC Bio is a venture capital fund based in San Francisco, California. Founded in 2018, it focuses on investing in early-stage life science companies that employ deep-tech approaches. Operating primarily in the San Francisco Bay Area, West Coast, and Western US regions, DCVC Bio has made notable investments in Frontier Medicines, Totus Medicines, Unlearn.AI, X-37, and Atomwise. With a strong emphasis on biotech, pharma, and Biomed sectors, DCVC Bio plays a significant role in supporting innovative companies in these fields.
Headquarters:
West Coast, New Zealand
Founded Date:
2018-01-01
Investor Type:
Venture Funds
Register and Claim Ownership